Results 301 to 310 of about 22,544,156 (338)

Vasoinhibin is Generated by the Renin-angiotensin System.

Endocrinology
Núñez FF, Siqueiros-Marquez L, Adán-Castro E, Zamora M, Robles JP, Ruíz-Herrera X, Bertsch T, Triebel J, Martínez de la Escalera G, Clapp C.   +9 more
europepmc   +1 more source

Cancer Stem Cells and the Renin-Angiotensin System in the Tumor Microenvironment of Melanoma: Implications on Current Therapies. [PDF]

Int J Mol Sci
Kilmister EJ, Tan ST.
europepmc   +1 more source

Renin-angiotensin system in intestinal inflammation – experimental studies with therapeutic interventions

, 2019
Hanne Salmenkari
openalex   +1 more source

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle, Linong Ji, Chantal Mathieu, Jonathan Rosen   +3 more
wiley   +1 more source

Exploring Renin-angiotensin System Genes as Novel Prognostic Biomarkers for Oral Squamous Cell Carcinoma. [PDF]

Int J Med Sci
Wu Z, Wang C, Han J, Chen X, Wu J, Cheng B, Wang J.   +6 more
europepmc   +1 more source

Comparison of the renal outcomes of novel antidiabetic agents in patients with type 2 diabetes with chronic kidney disease: A systematic review and network meta‐analysis of randomized controlled trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To investigate the renal outcomes of dipeptidyl peptidase 4 (DPP‐4) inhibitors, glucagon‐like peptide‐1 (GLP‐1) receptor agonists, and sodium‐glucose transport protein‐2 (SGLT‐2) inhibitors in patients with type 2 diabetes mellitus (T2DM) with chronic renal disease (CKD).
Rong Lin, Chia‐Li Hsu, Ming‐Chieh Shih, Kuo‐Liong Chien, Hon‐Yen Wu   +4 more
wiley   +1 more source

Discontinuing renin-angiotensin system inhibitors after incident hyperkalemia and clinical outcomes: target trial emulation. [PDF]

Hypertens Res
Hashimoto N, Sakaguchi Y, Hattori K, Kawano Y, Kawaoka T, Doi Y, Oka T, Kusunoki Y, Yamamoto S, Yamato M, Yamamoto R, Matsui I, Mizui M, Kaimori JY, Isaka Y.   +14 more
europepmc   +1 more source

Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromes

European Journal of Clinical Investigation, EarlyView.
Despite universal healthcare in Switzerland, disparities in post‐acute coronary syndrome (ACS) care persist across educational levels. In a cohort of 6040 patients, those with the lowest education had more cardiovascular risk factors and were less likely to attend cardiac rehabilitation or receive cardiology follow‐up.
Maëlle Achard, Cédric Follonier, Evelyne Fournier, David Carballo, Mattia Branca, Dik Heg, David Nanchen, Lorenz Räber, Roland Klingenberg, Stephan Windecker, Thomas F. Lüscher, Christian M. Matter, Nicolas Rodondi, François Mach, Baris Gencer   +14 more
wiley   +1 more source

Alterations in the Renin-Angiotensin System in Experimental Septic Shock. [PDF]

Crit Care Explor
Garcia B, Ter Schiphorst B, Su F, Picod A, Ikenna-Uba T, Favory R, Annoni F, Mebazaa A, Vincent JL, Creteur J, Taccone FS, Herpain A.   +11 more
europepmc   +1 more source